The Oncology Nurse-APN/PA spoke with Tonya Edwards, MS, RN, MSN, FNP-C, who discusses how The University of Texas M.D. Anderson Cancer Center focuses on counseling and supporting patients with cancer who receive opioids for pain relief.
The Oncology Nurse-APN/PA spoke with Shantell Utley, OCN, MSN, BSN, RN, about how oncology teams can consult an extended network of cancer specialists by virtual tumor boards to expand access to state-of-the-art cancer care for rural patients.
The Oncology Nurse-APN/PA spoke with Sandra Kurtin, PhDc, RN, MS, AOCN, ANP-C, a nurse practitioner who specializes in treating patients with hematologic malignancies at The University of Arizona Cancer Center as part of a multidisciplinary team.
The Oncology Nurse-APN/PA spoke with Salimah H. Meghani, PhD, MBE, RN, FAAN, a faculty member at the University of Pennsylvania School of Nursing, Philadelphia, about her various roles and thoughts on what is exciting in the field of palliative care.
Beth Faiman, PhD, APRN-BC, AOCN, is an author, presenter, and educator on the topics of multiple myeloma, general cancer diagnosis and treatment, and management of skeletal and other cancer-related complications.
Dr Bruner has had a distinguished career, marked by many awards (most recently, induction into the National Academy of Medicine), the publication of more than 150 peer-reviewed journal articles, and the distinction of being the first and only nurse to lead a National Cancer Institute cooperative group—the Radiation Therapy Oncology Group’s Community Clinical Oncology Program.
The Oncology Nurse-APN/PA (TON) spoke with Gayle Jameson, MSN, ACNP-BC, AOCN, Director, Supportive Care Division, Virginia G. Piper Cancer Center, Scottsdale, AZ, about her role in conducting cancer research at HonorHealth Research Institute.
The H. Lee Moffitt Cancer Center, Tampa, FL, is 1 of 47 National Cancer Institute–designated Comprehensive Care Centers in the United States, and is the only center based in Florida. Care at Moffitt is centered around the patient, and focuses on treating individuals with more common conditions compared with those with rare malignancies.